Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.

Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 14, 2022
Document Date
Dec 31, 2021
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vericel Corporation
Issuer
VERICEL CORP
Filer
Flynn Sean C.

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.